1. Funding capital expenditure requirements for setting up a new project to enhance existing manufacturing capacities and manufacture new products; and
2. General Corporate Purposes.
...
ated Consolidated Financial Statements. (Source: F&S Report) As per theF&S Report, during the Fiscal 2025, our Company recorded the highest RoCE of 36.43% and RoE of 33.91%,among its peers, thereby making it a key competitor in the industry. The Indian pharmaceutical market iswitnessing a value increase from USD 16.6 billion in 2019 to 38.3 billion in 2029, with an expected CAGR of8.0% between 2019 to 2024 to reach USD 20.13 billion and a further CAGR of 9.5% between 2024 to 2029. Thesmall molecule segment accounts for 80% - 90% of the total market, in 2024 by value as well as in terms ofvolume of drugs, with the biologics (including biosimilars) segment ranging between USD 4.5 to USD 5.5 billionin 2024. The IPM is ranked third in the world in terms of pharmaceutical production volumes contributed bygenerics, OTC drugs, other bulk drugs as well as contract research and manufacturing industry, and is amongstthe fastest growing pharma industries in the world. Read More
Posted on Jan 15th
Sterling and Wilson Renewable Energy informs about outcome of board meeting
Posted on Jan 15th
Democracy delivers in India as people are at centre of governance: PM Modi
Posted on Jan 14th
Aritas Vinyl coming with IPO to raise Rs 37.52 crore
Posted on Jan 14th
Currency futures for January expiry trade stronger with 0.58% decrease in OI
The issue size of Cotec Healthcare Ltd. IPO is ₹0.00 - 0.00 crore.
The Cotec Healthcare Ltd. IPO opens for subscription on and closes on .
The price range of Cotec Healthcare Ltd. IPO is ₹0.00 to ₹0.00.
The lot size of Cotec Healthcare Ltd. IPO is shares.
The registrar of Cotec Healthcare Ltd. IPO is KFIN Technologies Ltd..
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.